Section Arrow
ACAD.NASDAQ
- ACADIA Pharmaceuticals
Quotes are at least 15-min delayed:2024/04/29 09:26 EDT
Last
 --
-- (--)
Day High 
-- 
Prev. Close
16.71 
1-M High
18.63 
Volume 
-- 
Bid
16.52
Ask
17.03
Day Low
-- 
Open
-- 
1-M Low
16.16 
Market Cap 
2.75B 
Currency USD 
P/E -- 
%Yield
10-SMA 16.84 
20-SMA 17.37 
50-SMA 20.07 
52-W High 33.99 
52-W Low 16.16 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.37/1.46
Enterprise Value
2.80B
Balance Sheet
Book Value Per Share
2.62
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
726.44M
Operating Revenue Per Share
3.83
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ZYMEZymeworks----0.000%-- 
ZVSAZyVersa Therapeutics----0.000%-- 
ZVRAZevra Therapeutics----0.000%-- 
ZURAZura Bio Limited----0.000%15.76PE
ZNTLZentalis Pharmaceuticals----0.000%-- 
Quotes are at least 15-min delayed:2024/04/29 09:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.